<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id><journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id><journal-title-group><journal-title>Frontiers in Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1664-0640</issn><publisher><publisher-name>Frontiers Research Foundation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21423444</article-id><article-id pub-id-type="pmc">3059627</article-id><article-id pub-id-type="doi">10.3389/fpsyt.2010.00134</article-id><article-categories><subj-group subj-group-type="heading"><subject>Psychiatry</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Inverse Effects of Oxytocin on Attributing Mental Activity to Others in Depressed and Healthy Subjects: A Double-Blind Placebo Controlled fMRI Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pincus</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kose</surname><given-names>Samet</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Arana</surname><given-names>Ashley</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Morgan</surname><given-names>Paul S.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Borckardt</surname><given-names>Jeffrey</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Herbsman</surname><given-names>Tal</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hardaway</surname><given-names>Fran</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>George</surname><given-names>Mark S.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Panksepp</surname><given-names>Jaak</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nahas</surname><given-names>Ziad</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref><xref ref-type="author-notes" rid="fn001">*</xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>SUMMA Health, Akron</institution><country>OH, USA</country></aff><aff id="aff2"><sup>2</sup><institution>Mood Disorders Program and Brain Stimulation Laboratory, Department of Psychiatry, Medical University of South Carolina, Charleston</institution><country>SC, USA</country></aff><aff id="aff3"><sup>3</sup><institution>Center for Advanced Imaging Research, Medical University of South Carolina, Charleston</institution><country>SC, USA</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Psychiatry, Vanderbilt University, Nashville</institution><country>TN, USA</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Radiology, Medical University of South Carolina, Charleston</institution><country>SC, USA</country></aff><aff id="aff6"><sup>6</sup><institution>Department of Psychiatry, The Dean Clinics, Madison</institution><country>WI , USA</country></aff><aff id="aff7"><sup>7</sup><institution>Department of Neurosciences, Medical University of South Carolina, Charleston</institution><country>SC, USA</country></aff><aff id="aff8"><sup>8</sup><institution>Ralph H. Johnson VA, Charleston</institution><country>SC, USA</country></aff><aff id="aff9"><sup>9</sup><institution>Washington State University, Pullman</institution><country>WA, USA</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by:Zafiris J. Daskalakis, University of Toronto, Canada</p></fn><fn fn-type="edited-by"><p>Reviewed by:Paul Croarkin, UT Southwestern Medical Center, USA; Tarek Rajji, Centre for Addiction and Mental Health, Canada</p></fn><corresp id="fn001">*Correspondence:Ziad Nahas, Department of Psychiatry and Behavioral Sciences, Institute of Psychiatry, 67 President St., Charleston, SC 29425, USA.; e-mail: <email>nahasz@musc.edu</email></corresp></author-notes><pub-date pub-type="epreprint"><day>13</day><month>8</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>12</day><month>10</month><year>2010</year></pub-date><pub-date pub-type="collection"><year>2010</year></pub-date><volume>1</volume><elocation-id>134</elocation-id><history><date date-type="received"><day>18</day><month>7</month><year>2010</year></date><date date-type="accepted"><day>23</day><month>8</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2010 Pincus, Kose, Arana, Johnson, Morgan, Borckardt, Herbsman, Hardaway, George, Panksepp and Nahas.</copyright-statement><copyright-year>2010</copyright-year><license license-type="open-access" xlink:href="http://www.frontiersin.org/licenseagreement"><license-p>This is an open-access article subject to an exclusive license agreement between the authors and the Frontiers Research Foundation, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.</license-p></license></permissions><abstract><p><bold>Background:</bold> Oxytocin is a stress-attenuating and pro-social neuropeptide. To date, no study has looked at the effects of oxytocin in modulating brain activity in depressed individuals nor attempted to correlate this activity with attribution of mental activity in others. <bold>Method:</bold> We enrolled 10 unmedicated depressed adults and 10 matched healthy controls in a crossover, double blind placebo controlled fMRI 40 i.u. intra-nasal oxytocin study (20 i.u. per nostril). Each subject performed reading the mind in the eyes task (RMET) before and after inhalation of oxytocin or placebo control for a total of 80 scans. <bold>Results:</bold> Before oxytocin administration, RMET engaged the medial and lateral prefrontal cortex, amygdala, insula and associative areas. Depressed subjects showed increased anterior ventral activation for the RMET minus gender identification contrast whereas matched controls showed increased dorsal and frontal activity. Compared to placebo, oxytocin in depressed subjects showed increased activity in the superior middle frontal gyrus and insula, while controls exhibited more activity in ventral regions. Oxytocin also led to inverse effects in reaction times on attribution task between groups, with controls getting faster and depressed individuals slower to respond. <bold>Conclusion:</bold> Depression is associated with increased paralimbic activity during emotional mental attribution of others, appearing to be distinctly modulated by oxytocin when compared to healthy controls. Further studies are needed to explore long-term exposure to pro-social neuropeptides on mood in depressed populations and assess their clinical relevance.</p></abstract><kwd-group><kwd>oxytocin</kwd><kwd>fMRI</kwd><kwd>mentalization</kwd><kwd>theory of mind</kwd><kwd>depression</kwd></kwd-group><counts><fig-count count="4"/><table-count count="3"/><equation-count count="0"/><ref-count count="55"/><page-count count="10"/><word-count count="7393"/></counts></article-meta></front><body><sec><title>Introduction</title><p>Mentalization, a developmentally derived ability to affectively and cognitively infer the mental state of others is crucial to sociality and is enhanced by propitious genetics and secure attachments (Choi-Kain and Gunderson, <xref ref-type="bibr" rid="B6">2008</xref>; Hartmann, <xref ref-type="bibr" rid="B20">2009</xref>). Mentalization allows individuals to estimate others&#x02019; states of mind, and one's reactions and reflections upon that approximation represent an advantageous ability given that humans need good social bonds for maximum health, adaptation, and richer relationships. It begins in infancy and is facilitated by positive social interactions (Fonagy and Target, <xref ref-type="bibr" rid="B13">2007</xref>) and early attachment experiences (Meins et al., <xref ref-type="bibr" rid="B32">2002</xref>).</p><p>Although little is known about the neurophysiology of such experiences, there is evidence that oxytocin, a neuropeptide, promotes positive social interactions and preferences (Hurlemann et al., <xref ref-type="bibr" rid="B22">2010</xref>), Winslow and Insel, <xref ref-type="bibr" rid="B52">2004</xref>; Zak et al., <xref ref-type="bibr" rid="B55">2005</xref>), enhances socially reinforced learning and faces recognition (Marsh et al., <xref ref-type="bibr" rid="B28">2010</xref>), Guastella et al., <xref ref-type="bibr" rid="B17">2008</xref>), exerts anxiolytic effects and is a key modulator of early mother-infant bonding and maternal caretaking (Panksepp, <xref ref-type="bibr" rid="B37">2005</xref>). It is increasingly released in affectively rich dyadic settings such a when social attunement occurs between mother and infant, in breastfeeding, early skin to skin contact, and later in sexual intercourse and climax (Nelson and Panksepp, <xref ref-type="bibr" rid="B33">1998</xref>; Uvnas-Moberg, <xref ref-type="bibr" rid="B48">1998</xref>). Conversely, low levels of oxytocin have been linked to depression (Bell, <xref ref-type="bibr" rid="B4">2006</xref>), with patients experiencing and observed to possess &#x0201c;dis-affiliation&#x0201d; with others. Also, critical social events marked with insecure attachment or losses of significant others often precipitate depressive symptoms (Anisman, <xref ref-type="bibr" rid="B1">1984</xref>). Functional neuroimaging studies consistently find abnormal ventral limbic and paralimbic activity in depression (Price and Drevets, <xref ref-type="bibr" rid="B41">2009</xref>) &#x02013; the very same regions implicated in the mediation of social relatedness and mentalization (Choi-Kain and Gunderson, <xref ref-type="bibr" rid="B6">2008</xref>; Hartmann, <xref ref-type="bibr" rid="B20">2009</xref>).</p><p>Theory of mind (ToM) is a research and conceptual rubric of an &#x0201c;imagined involvement&#x0201d; that was derived from studies of autism. Mentalization is a higher order capacity, either deficient in clinical populations or progressively enhanced with better caretaking and affective attunement. The failure to evolve mentalization partially explains pervasive developmental disorders (Ozonoff et al., <xref ref-type="bibr" rid="B36">1991</xref>; Happe, <xref ref-type="bibr" rid="B19">1994</xref>; Happe et al., <xref ref-type="bibr" rid="B18">1996</xref>), schizophrenia (Pilowsky et al., <xref ref-type="bibr" rid="B39">2000</xref>) and reduced social interactions in depression (Uekermann et al., <xref ref-type="bibr" rid="B47">2008</xref>). Lower social function is associated with higher risks for symptom recurrence 1 year after recovering from a major depressive episode (Uekermann et al., <xref ref-type="bibr" rid="B47">2008</xref>). The interest in mirror neurons (Rizzolatti and Fabbri-Destro, <xref ref-type="bibr" rid="B43">2008</xref>) provides a potential neural basis for intent prediction of others. Imaging studies using single photon emission computed tomography (SPECT) (Vogeley et al., <xref ref-type="bibr" rid="B50">2001b</xref>), positron emission tomography (PET) (Happe et al., <xref ref-type="bibr" rid="B18">1996</xref>) or fMRI (Gallagher et al., <xref ref-type="bibr" rid="B14">2000</xref>) have utilized different ToM paradigms (Stuss et al., <xref ref-type="bibr" rid="B46">2001</xref>; Vogeley et al., <xref ref-type="bibr" rid="B49">2001a</xref>) with mixed results. These studies do, however, shed light upon functional networks correlated with mentalization and the social nature of the self and point to the amygdala, the superior temporal gyrus, and medial and orbito-frontal cortex as keys to this high-order mental process.</p><p>A &#x0201c;Reading the Mind in the Eyes test&#x0201d; (RMET) (Baron-Cohen et al., <xref ref-type="bibr" rid="B3">2001</xref>) was developed to study emotional mental attribution. This task requires the subject to infer the mental state of an individual from the expression in their eyes and immediately surrounding areas, a measure of imagined involvement as opposed to an appraisal task. Brain regions previously shown to be significantly activated by the task include fronto-temporal neocortical regions, such as left dorsolateral prefrontal cortex, medial frontal cortex and superior temporal gyrus as well as non-cortical regions such as left amygdala, left hippocampus, bilateral insula and left striatum, with some of the brain changes being culture specific (Johnston et al., <xref ref-type="bibr" rid="B25">2005</xref>; Baron-Cohen et al., <xref ref-type="bibr" rid="B2">2006</xref>; Williams et al., <xref ref-type="bibr" rid="B51">2008</xref>).</p><p>To date, no studies have investigated the functional neuroanatomy of mentalization in depression nor the effects of oxytocin in modulating brain activity in depressed individuals. Accordingly, we used the RMET task and an intra-nasal oxytocin challenge to investigate mentalization in unmedicated depressed patients and healthy controls. We hypothesized that depressed patients may show greater limbic activity during the mentalization task compared to matched controls, and that oxytocin will lead to a significant decrease in ventro-limbic activity when compared to placebo.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Design</title><p>This is a randomized double-blind crossover design to investigate the acute effects of intra-nasal oxytocin on mentalization in unmedicated depressed patients and matched controls. Primary outcome measures consisted of functional blood oxygen level dependent MRI (BOLD fMRI) scans. Secondary outcome measures were behavioral measures (speed of reaction time). This study was approved by the Medical University of South Carolina (MUSC) Institutional Review Board funded by a grant from the Hope for Depression Research Foundation, and collaboratively conducted with the MindBrain Consortium at Summa Hospitals, Akron, Ohio.</p></sec><sec><title>Subjects</title><p>Subjects were recruited from the MUSC outpatient psychiatric services, the Mood Disorders Program (MDP) and through local advertisement. We screened 15 Healthy and 20 Depressed subjects and enrolled 22 adult subjects. All subjects signed written informed consent. Depressed patients met criteria for major depressive episode by Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) criteria of less than 24&#x02009;months in duration with an antidepressant treatment history form (ATHF) severity one or less failed trials. Healthy controls were screened for any active DSM-IV-TR Axis I diagnosis (with the exception of caffeine or nicotine abuse). Subjects were off all psychotropic medications for at least 2 weeks prior to first scanning session. Subjects were excluded if they were medically unstable or had an active neurodegenerative or epilepsy disorder. All presented data are from subjects who completed a baseline clinical assessment visit along with two scanning sessions over a maximum of 3&#x02009;weeks period.</p></sec><sec><title>Scanning and drug inhalation procedures</title><p>At each scanning session, subjects underwent two identical blood oxygentation dependant (BOLD) fMRI scans before and approximately 10&#x02009;min after inhalation of study drug (20 IU oxytocin or placebo per nostril; Lee-Silsby Pharmacy, Cleveland, OH, USA). The oxytocin dose is comparable to that used previously in human studies of behavior (Epperson et al., <xref ref-type="bibr" rid="B11">1996a</xref>,<xref ref-type="bibr" rid="B12">1996b</xref>; Ditzen et al., <xref ref-type="bibr" rid="B9">2007</xref>). Randomization and subject's assignment were performed by MUSC Investigational Drug Services and the McClellan Banks Pharmacy. Data was unmasked after study completion and all data were locked. Subjects abstained from alcohol and nicotine for 12&#x02009;h before the experiment.</p></sec><sec><title>Reading the mind in the eyes paradigm</title><p>We adapted the reading the mind in the eyes paradigm (RMET) for presentation in the scanner and an event-fMRI design. We used the Integrated Functional Imaging System (IFIS-SA) (Invivo, Orlando, FL, USA) to visually present the paradigm and record responses of the participants. The RMET task consisted of three conditions: affect attribution of faces cropped around the eyes in rectangular shape (referred in the text as RMET), gender identification of the same photographs, and a basic motor cued response. Possible attribute adjectives, gender attributes (&#x0201c;male,&#x0201d; &#x0201c;female&#x0201d;) and motor cues (&#x0201c;yes,&#x0201d; &#x0201c;no&#x0201d;) were positioned at the four corners with optimal or normed responses equally randomized for all presentations. Participants pressed a hand-pad button to indicate their attribute of choice. On the hand-pad, the left and right index fingers corresponded to the top left and top right corners of images, and the left and right thumbs corresponded to the bottom left and bottom right corners of images. This entire paradigm consisted of 32 events for each condition (96 events total presented in a fixed-randomized order) and lasted approximately 769&#x02009;s. The duration of each event lasted 7&#x02009;s, separated by a jittered inter-stimulus black screen [inter-stimulus interval (ISI) range 6&#x02013;4753&#x02009;ms, ISI average&#x02009;=&#x02009;1008&#x02009;ms].</p></sec><sec><title>Image acquisition</title><p>Images were acquired using a 3T MRI scanner (Intera, Philips Medical System, Netherlands) with a SENSE parallel imaging head-coil. A sagittal reference image was first acquired, to guide positioning of the functional scans along the anterior commissure-posterior commissure line. For scanning during the RMET paradigm, echoplanar (EPI) transverse images were acquired with the following parameters: 414 volumes, repetition time =&#x02009;1867&#x02009;ms, echo time&#x02009;=&#x02009;30&#x02009;ms, flip angle =&#x02009;90&#x000b0;, field of view =&#x02009;208&#x02009;mm, matrix&#x02009;=&#x02009;64&#x02009;&#x000d7;&#x02009;64, SENSE factor&#x02009;=&#x02009;2, 32 slices, 3.25&#x02009;mm with no gap, yielding a voxel size of 3.3 &#x000d7;&#x02009;3.3 &#x000d7;&#x02009;3.25&#x02009;mm<sup>3</sup>.</p></sec><sec><title>Data analysis</title><sec><title>Demographics and psychological measures</title><p>Descriptive statistics were performed using SPSS 16.0 for Macintosh (SPSS Inc., Chicago, IL, USA) and included mean, standard deviation, Student's <italic>t</italic>-test, Pearson Chi-square test. All tests were two-tailed at 0.05 significant level and assumed equal variance.</p></sec><sec><title>fMRI data processing methods</title><p>fMRI image data was first transferred to a workstation where it was converted into Analyze format using MRICro<sup>1</sup><xref ref-type="fn" rid="fn1"/> and then subjected to the following pre-statistics processing steps using FMRI FEAT (FMRI Expert Analysis Tool) Version 5.92, part of FSL (FMRIB's Software Library<sup>2</sup><xref ref-type="fn" rid="fn2"/>). Each dataset was spatially normalized into an high resolution structural scan MNI template with FLIRT (Jenkinson and Smith, <xref ref-type="bibr" rid="B24">2001</xref>; Jenkinson et al., <xref ref-type="bibr" rid="B23">2002</xref>) We applied MCFLIRT for motion correction (Jenkinson et al., <xref ref-type="bibr" rid="B23">2002</xref>) and reviewed all datasets for remaining motion, which was less than 0.5&#x02009;mm along all three major axes (<italic>x</italic>, <italic>y</italic>, <italic>z</italic>) for all subjects. In addition, we applied non-brain removal using BET (Smith, <xref ref-type="bibr" rid="B45">2002</xref>); spatial smoothing using a Gaussian kernel of FWHM 8.0&#x02009;mm; grand-mean intensity normalization of the entire 4D dataset by a single multiplicative factor and highpass temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma&#x02009;=&#x02009;50.0&#x02009;s).</p></sec><sec><title>Behavioral data</title><p>Individual responses collected by IFIS during RMET were collated, checked for missing responses and collated in an Excel spreadsheet. Reaction Time (RT) and Accuracy of Response (AC) were noted. Final analysis included mean, standard deviation, Student's <italic>t</italic>-test, and Pearson Chi-square test. All tests were two-tailed and assumed equal variance.</p><p>For mixed models examining the effects of drug by time, pre-drug administration conditions were coded in the dataset as &#x0201c;0,&#x0201d; post-drug were coded as &#x0201c;1,&#x0201d; placebo conditions were coded as &#x0201c;0&#x0201d; and oxytocin conditions were coded as &#x0201c;1.&#x0201d; Hierarchical Linear Modeling (HLM) was implemented using PROC MIXED in SAS (SAS Institute Inc., Cary, NC) to assess the linear effect of the interaction of &#x0201c;time&#x0201d; (pre to post-drug administration) and &#x0201c;treatment type&#x0201d; (oxytocin versus placebo) on reaction time and accuracy of response between groups (thereby by testing a series of 2 &#x000d7;&#x02009;2 &#x000d7;&#x02009;2 mixed models). HLM has been shown to handle nested models with serially dependent data points and randomly distributed missing values appropriately (Raudenbush and Chan, <xref ref-type="bibr" rid="B42">1993</xref>; de Leeuw and Kreft, <xref ref-type="bibr" rid="B8">1995</xref>; Hoffman and Gavin, <xref ref-type="bibr" rid="B21">1998</xref>; Nezlek and Zyzniewski, <xref ref-type="bibr" rid="B34">1998</xref>). Additionally, this approach is growing in popularity among clinical and educational researchers due to its flexibility and appropriateness for data typically encountered in clinical and social science research (Sliwinski and Hall, <xref ref-type="bibr" rid="B44">1998</xref>; Kuo et al., <xref ref-type="bibr" rid="B27">2000</xref>; McGuigan et al., <xref ref-type="bibr" rid="B31">2003</xref>). The covariance structure was &#x0201c;unstructured&#x0201d; and the estimation method was REML.</p></sec><sec><title>fMRI statistical analysis</title><p>Time-series statistical analysis was carried out using FILM with local autocorrelation correction (Woolrich et al., <xref ref-type="bibr" rid="B53">2001</xref>). Potentially confounding motion over time was regressed out. <italic>Z</italic> (Gaussianized T/F) statistic images were thresholded using clusters determined by <italic>Z</italic> &#x0003e;&#x02009;2.3 and a (corrected) cluster significance threshold of <italic>p</italic> =&#x02009;0.05 (Worsley, <xref ref-type="bibr" rid="B54">2001</xref>) for identification of voxels with statistically significant activation during three conditions in individual subjects (fixed effect). We then performed a group mean (baseline depressed +&#x02009;matched controls) and unpaired <italic>t</italic>-tests between oxytocin and placebo conditions (random effect; FLAME 1 +&#x02009;2 option).</p></sec></sec></sec><sec><title>Results</title><p>Eight unmedicated depressed subjects (eight females, four African-Americans, four Caucasians) and nine matched controls (eight females, five African-Americans, four Caucasians) completed all assessments required for this study. The mean age for depressed subjects was 35.5&#x02009;years (SD&#x02009;=&#x02009;10.62), ranging from 26 to 60, and for controls, 36.4&#x02009;years (SD =&#x02009;11.40), ranging from 25 to 59. Mean years of education post high school were 2.56 (SD =&#x02009;1.95) for depressed subjects and 4.22 (SD =&#x02009;1.79) for controls. Co-morbidities of depressed subjects included a past history of alcohol dependence (<italic>n</italic> =&#x02009;2), social phobia (<italic>n</italic> =&#x02009;1), obsessive compulsive disorder (<italic>n</italic> =&#x02009;1), panic disorder without agoraphobia (<italic>n</italic> =&#x02009;2), anxiety (<italic>n</italic> =&#x02009;1), and anorexia nervosa (<italic>n</italic> =&#x02009;1). All subjects were right handed. Sixteen subjects were employed either part or full time, and one was a homemaker. The patient cohort had significant depressive and anxiety symptoms compared to healthy controls and tended to show reduced capacity for empathy but not? overall emotional intelligence as measured by the Mayer&#x02013;Salovey&#x02013;Caruso Emotional Intelligence Test (MSCEIT) (Mayer et al., <xref ref-type="bibr" rid="B30">2003</xref>) (See Table <xref ref-type="table" rid="T1">1</xref>). There was a significant inverse correlation between subjective depressive symptoms (IDS-SR) and empathy quotient (df =&#x02009;21, <italic>r</italic><sup>2</sup> =&#x02009;0.35, <italic>p</italic> =&#x02009;0.004).</p><table-wrap id="T1" position="float"><caption><p><bold>Table 1. Demographics and clinical characteristics of unmedicated depressed subjects and their matched healthy controls</bold>. Significant differences were found in depressive symptoms (HDRS, IDS-SR, ANPS-Sadness), anxiety symptoms (STAY-I and ANPS-Fear), and capacity to care (ANPS-Care). Note that a trend for differences on Empathy Quotient and ANPS-Spirituality.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Depressed</th><th align="left" rowspan="1" colspan="1">Controls</th><th align="left" rowspan="1" colspan="1">Significance</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;35.5, SD&#x02009;=&#x02009;10.62</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;36.4, SD&#x02009;=&#x02009;11.40</td><td align="left" rowspan="1" colspan="1">0.86</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">8 Female</td><td align="left" rowspan="1" colspan="1">8 Female, 1 male</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Race</td><td align="left" rowspan="1" colspan="1">4 African-American, 4 White</td><td align="left" rowspan="1" colspan="1">5 African-American, 4 White</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Marital status</td><td align="left" rowspan="1" colspan="1">5 Single, 2 married, 1 separated</td><td align="left" rowspan="1" colspan="1">3 Single, 4 married, 2 separated</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Education (years post high school)</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;2.56, SD&#x02009;=&#x02009;1.95</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;4.22, SD&#x02009;=&#x02009;1.79</td><td align="left" rowspan="1" colspan="1">0.087</td></tr><tr><td align="left" rowspan="1" colspan="1">Employment</td><td align="left" rowspan="1" colspan="1">8 Full time, 1 part time</td><td align="left" rowspan="1" colspan="1">4 Full time, 3 part time, 1 homemaker</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HRSD</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;21.38, SD&#x02009;=&#x02009;5.15</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;1.4, SD&#x02009;=&#x02009;1.42</td><td align="left" rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">IDS-SR 30 items</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;32.75, SD&#x02009;=&#x02009;11.25</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;3.78, SD&#x02009;=&#x02009;3.53</td><td align="left" rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">STAI Y-2</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;55.75, SD&#x02009;=&#x02009;7.92</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;26.88, SD&#x02009;=&#x02009;3.72</td><td align="left" rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">ANPS-seeking</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;21.38, SD&#x02009;=&#x02009;4.00</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;23.89, SD&#x02009;=&#x02009;3.02</td><td align="left" rowspan="1" colspan="1">0.161</td></tr><tr><td align="left" rowspan="1" colspan="1">ANPS-fear</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;21.88, SD&#x02009;=&#x02009;1.13</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;19.44, SD&#x02009;=&#x02009;1.67</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">ANPS-care</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;23.38, SD&#x02009;=&#x02009;1.77</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;18.22, SD&#x02009;=&#x02009;2.64</td><td align="left" rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">ANPS-anger</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;20.75, SD&#x02009;=&#x02009;1.83</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;19.22, SD&#x02009;=&#x02009;3.53</td><td align="left" rowspan="1" colspan="1">0.290</td></tr><tr><td align="left" rowspan="1" colspan="1">ANPS-play</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;20.38, SD&#x02009;=&#x02009;2.67</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;22.00, SD&#x02009;=&#x02009;2.40</td><td align="left" rowspan="1" colspan="1">0.206</td></tr><tr><td align="left" rowspan="1" colspan="1">ANPS-sadness</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;23.63, SD&#x02009;=&#x02009;2.50</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;17.67, SD&#x02009;=&#x02009;2.45</td><td align="left" rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">ANPS-spirituality</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;18.75, SD&#x02009;=&#x02009;1.58</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;16.33, SD&#x02009;=&#x02009;2.96</td><td align="left" rowspan="1" colspan="1">0.057</td></tr><tr><td align="left" rowspan="1" colspan="1">MSCEIT total</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;96.08, SD&#x02009;=&#x02009;21.31</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;101.26, SD&#x02009;=&#x02009;15.45</td><td align="left" rowspan="1" colspan="1">0.596</td></tr><tr><td align="left" rowspan="1" colspan="1">Empathy quotient</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;40.00, SD&#x02009;=&#x02009;12.44</td><td align="left" rowspan="1" colspan="1"><italic>M</italic>&#x02009;=&#x02009;49.67, SD&#x02009;=&#x02009;8.09</td><td align="left" rowspan="1" colspan="1">0.074</td></tr></tbody></table></table-wrap><sec><title>Behavioral results</title><sec><title>Reaction time</title><p>Figure <xref ref-type="fig" rid="F1">1</xref> shows reaction time slope changes with intra-nasal oxytocin in healthy controls and depressed subjects across RMET, gender attribution, and motor cued response. A significant effect was found for the slope of the drug &#x000d7;&#x02009;time &#x000d7;&#x02009;group reaction time (RT) interaction during RMET [<italic>F</italic>(1,2551) =&#x02009;5.99, <italic>p</italic> =&#x02009;0.015]. A decreased RT slope was found in healthy matched controls [<italic>t</italic>(2551) =&#x02009;2.20, <italic>p</italic> =&#x02009;0.028] relative to an increased slope in depressed subjects [<italic>t</italic>(2551) =&#x02009;2.45, <italic>p</italic> =&#x02009;0.015], suggesting that oxytocin administration was associated with faster reaction times in the healthy cohort and slower reaction times in the depressed cohort after controlling for placebo and pre-drug performance. A significant effect was also found for the slope of the drug &#x000d7;&#x02009;time &#x000d7;&#x02009;group RT interaction during gender attribution [<italic>F</italic>(1,2510) =&#x02009;14.82, <italic>p</italic> &#x0003c;&#x02009;0.0001]. Again, a decreased RT slope was found in healthy matched controls [<italic>t</italic>(2510) =&#x02009;4.27, <italic>p</italic> &#x0003c;&#x02009;0.0001] relative to an increased slope in depressed subjects [<italic>t</italic>(2510) =&#x02009;3.85, <italic>p</italic> &#x0003c;&#x02009;0.0001]. Again, this suggests that oxytocin administration was associated with faster reaction times in the healthy cohort and slower reaction times in the depressed cohort after controlling for placebo and pre-drug performance. <italic>Lastly</italic>, a significant effect was found for the slope of the drug &#x000d7;&#x02009;time &#x000d7;&#x02009;group RT interaction during motor cued response [<italic>F</italic>(1,2507) =&#x02009;6.87, <italic>p</italic> =&#x02009;0.009]. Oxytocin administration was associated with decreased RT slope in healthy matched controls [<italic>t</italic>(2507) =&#x02009;2.92, <italic>p</italic> =&#x02009;0.004] relative to an increased slope in depressed subjects [<italic>t</italic>(2507) =&#x02009;2.62, <italic>p</italic> =&#x02009;0.009] after controlling for placebo and pre-treatment performance. The mean effect size (Cohen's d) across all RT for oxytocin is small at 0.18. Table <xref ref-type="table" rid="T2">2</xref> shows the mean values (and standard error) for each variable pre to post-oxytocin or placebo.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Reaction time slope changes with intra-nasal oxytocin in healthy matched controls (blue) and depressed subjects (red) across RMET, gender attribution and motor cued response</bold>.</p></caption><graphic xlink:href="fpsyt-01-00134-g001"/></fig><table-wrap id="T2" position="float"><caption><p><bold>Table 2. Reaction times (RT) in milliseconds and accuracy of response (AC) in unmedicated depressed subjects and their matched healthy controls during fMRI sessions</bold>. Data represent mean and standard deviation across three variables (RMET, gender attribution, and cued-motor response) and four conditions (pre-oxytocin, post-oxytocin, pre-placebo, and post-placebo).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Pre-placebo</th><th align="left" rowspan="1" colspan="1">Pre-oxytocin</th><th align="left" rowspan="1" colspan="1">Post-placebo</th><th align="left" rowspan="1" colspan="1">Post-oxytocin</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RT RMET</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Matched controls</td><td align="left" rowspan="1" colspan="1">4396.3&#x02009;&#x000b1;&#x02009;1499.8</td><td align="left" rowspan="1" colspan="1">4198.5&#x02009;&#x000b1;&#x02009;1728.6</td><td align="left" rowspan="1" colspan="1">4092.5&#x02009;&#x000b1;&#x02009;1560.8</td><td align="left" rowspan="1" colspan="1">4222.8&#x02009;&#x000b1;&#x02009;1293</td></tr><tr><td align="left" rowspan="1" colspan="1">Depressed</td><td align="left" rowspan="1" colspan="1">3945.1&#x02009;&#x000b1;&#x02009;1260.7</td><td align="left" rowspan="1" colspan="1">4201.6&#x02009;&#x000b1;&#x02009;1169.3</td><td align="left" rowspan="1" colspan="1">3878.5&#x02009;&#x000b1;&#x02009;1328.3</td><td align="left" rowspan="1" colspan="1">4119.8&#x02009;&#x000b1;&#x02009;1297.2</td></tr><tr><td align="left" rowspan="1" colspan="1">RT gender attribution</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Matched controls</td><td align="left" rowspan="1" colspan="1">2168.7&#x02009;&#x000b1;&#x02009;958.3</td><td align="left" rowspan="1" colspan="1">2126.1&#x02009;&#x000b1;&#x02009;853.3</td><td align="left" rowspan="1" colspan="1">2023.2&#x02009;&#x000b1;&#x02009;950.7</td><td align="left" rowspan="1" colspan="1">1936.4&#x02009;&#x000b1;&#x02009;710.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Depressed</td><td align="left" rowspan="1" colspan="1">1673.7&#x02009;&#x000b1;&#x02009;651.6</td><td align="left" rowspan="1" colspan="1">1787.4&#x02009;&#x000b1;&#x02009;717.6</td><td align="left" rowspan="1" colspan="1">1648.3&#x02009;&#x000b1;&#x02009;774.5</td><td align="left" rowspan="1" colspan="1">1771.3&#x02009;&#x000b1;&#x02009;880.8</td></tr><tr><td align="left" rowspan="1" colspan="1">RT motor cued response</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Matched controls</td><td align="left" rowspan="1" colspan="1">1416.8&#x02009;&#x000b1;&#x02009;592</td><td align="left" rowspan="1" colspan="1">1464.4&#x02009;&#x000b1;&#x02009;730.2</td><td align="left" rowspan="1" colspan="1">1363.1&#x02009;&#x000b1;&#x02009;791.9</td><td align="left" rowspan="1" colspan="1">1351.7&#x02009;&#x000b1;&#x02009;465.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Depressed</td><td align="left" rowspan="1" colspan="1">1214.7&#x02009;&#x000b1;&#x02009;472.9</td><td align="left" rowspan="1" colspan="1">1257.6&#x02009;&#x000b1;&#x02009;505</td><td align="left" rowspan="1" colspan="1">1134.6&#x02009;&#x000b1;&#x02009;461.8</td><td align="left" rowspan="1" colspan="1">1240.5&#x02009;&#x000b1;&#x02009;395.9</td></tr><tr><td align="left" rowspan="1" colspan="1">AC RMET</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Matched controls</td><td align="left" rowspan="1" colspan="1">60.6%</td><td align="left" rowspan="1" colspan="1">59.4%</td><td align="left" rowspan="1" colspan="1">64.2%</td><td align="left" rowspan="1" colspan="1">67.9%</td></tr><tr><td align="left" rowspan="1" colspan="1">Depressed</td><td align="left" rowspan="1" colspan="1">65.8%</td><td align="left" rowspan="1" colspan="1">67%</td><td align="left" rowspan="1" colspan="1">67%</td><td align="left" rowspan="1" colspan="1">70.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">AC gender attribution</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Matched controls</td><td align="left" rowspan="1" colspan="1">89.4%</td><td align="left" rowspan="1" colspan="1">82.8%</td><td align="left" rowspan="1" colspan="1">87.8%</td><td align="left" rowspan="1" colspan="1">90%</td></tr><tr><td align="left" rowspan="1" colspan="1">Depressed</td><td align="left" rowspan="1" colspan="1">87.2%</td><td align="left" rowspan="1" colspan="1">88.1%</td><td align="left" rowspan="1" colspan="1">83.8%</td><td align="left" rowspan="1" colspan="1">86.9%</td></tr><tr><td align="left" rowspan="1" colspan="1">AC motor cued response</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Matched controls</td><td align="left" rowspan="1" colspan="1">98.1%</td><td align="left" rowspan="1" colspan="1">94.1%</td><td align="left" rowspan="1" colspan="1">93.1%</td><td align="left" rowspan="1" colspan="1">97.8%</td></tr><tr><td align="left" rowspan="1" colspan="1">Depressed</td><td align="left" rowspan="1" colspan="1">96.9%</td><td align="left" rowspan="1" colspan="1">97.5%</td><td align="left" rowspan="1" colspan="1">95.6%</td><td align="left" rowspan="1" colspan="1">97.2%</td></tr></tbody></table></table-wrap></sec><sec><title>Accuracy of response</title><p>There were no significant changes with accuracy of response (AR) across variables or conditions. Table <xref ref-type="table" rid="T2">2</xref> summarizes the findings described above and Table <xref ref-type="table" rid="T2">2</xref> shows the mean values (and standard error) for each variable pre to post-oxytocin or placebo. No significant antidepressant effects of oxytocin were observed in this provocation-paradigm study.</p></sec></sec><sec><title>Functional imaging</title><p>The corresponding brain atlas coordinates and the fMRI activations for healthy controls and depressed subjects are presented in Table 3.</p><table-wrap id="T3" position="float"><caption><p><bold>Table 3. fMRI activations Talairach coordinates and corresponding <italic>z</italic>-scores</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">z-Score</th><th align="left" rowspan="1" colspan="1">x</th><th align="left" rowspan="1" colspan="1">y</th><th align="left" rowspan="1" colspan="1">z</th><th align="left" rowspan="1" colspan="1">Left/right</th><th align="left" rowspan="1" colspan="1">Region</th><th align="left" rowspan="1" colspan="1">Brodmann area</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>BASELINE GROUPS ANALYSIS</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Healthy controls <italic>n</italic>&#x02009;=&#x02009;9</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>RMET group mean</bold></italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">5.7</td><td align="left" rowspan="1" colspan="1">&#x02212;46</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Middle frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 9</td></tr><tr><td align="left" rowspan="1" colspan="1">5.57</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">&#x02212;64</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior parietal lobule</td><td align="left" rowspan="1" colspan="1">Brodmann area 7</td></tr><tr><td align="left" rowspan="1" colspan="1">5.51</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 6</td></tr><tr><td align="left" rowspan="1" colspan="1">5.4</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">&#x02212;62</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior parietal lobule</td><td align="left" rowspan="1" colspan="1">Brodmann area 7</td></tr><tr><td align="left" rowspan="1" colspan="1">5.19</td><td align="left" rowspan="1" colspan="1">&#x02212;20</td><td align="left" rowspan="1" colspan="1">&#x02212;64</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior parietal lobule</td><td align="left" rowspan="1" colspan="1">Brodmann area 7</td></tr><tr><td align="left" rowspan="1" colspan="1">4.87</td><td align="left" rowspan="1" colspan="1">&#x02212;32</td><td align="left" rowspan="1" colspan="1">&#x02212;84</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Inferior occipital gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 18</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>RMET minus gender group mean</bold></italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 6</td></tr><tr><td align="left" rowspan="1" colspan="1">4.39</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Caudate</td><td align="left" rowspan="1" colspan="1">Caudate Body</td></tr><tr><td align="left" rowspan="1" colspan="1">4.32</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Medial frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 9</td></tr><tr><td align="left" rowspan="1" colspan="1">3.99</td><td align="left" rowspan="1" colspan="1">&#x02212;12</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 9</td></tr><tr><td align="left" rowspan="1" colspan="1">3.91</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 10</td></tr><tr><td align="left" rowspan="1" colspan="1">3.85</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">&#x02212;40</td><td align="left" rowspan="1" colspan="1">&#x02212;4</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Middle temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 21</td></tr><tr><td align="left" rowspan="1" colspan="1">5.79</td><td align="left" rowspan="1" colspan="1">&#x02212;46</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 47</td></tr><tr><td align="left" rowspan="1" colspan="1">5.21</td><td align="left" rowspan="1" colspan="1">&#x02212;54</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 45</td></tr><tr><td align="left" rowspan="1" colspan="1">4.52</td><td align="left" rowspan="1" colspan="1">&#x02212;52</td><td align="left" rowspan="1" colspan="1">&#x02212;48</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Middle temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 22</td></tr><tr><td align="left" rowspan="1" colspan="1">3.79</td><td align="left" rowspan="1" colspan="1">&#x02212;42</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">&#x02212;36</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Middle temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 21</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Unmedicated depressed <italic>n</italic>&#x02009;=&#x02009;8</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>RMET group mean</bold></italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">5.29</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Cingulate gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 32</td></tr><tr><td align="left" rowspan="1" colspan="1">4.83</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Insula</td><td align="left" rowspan="1" colspan="1">Brodmann area 13</td></tr><tr><td align="left" rowspan="1" colspan="1">4.66</td><td align="left" rowspan="1" colspan="1">&#x02212;22</td><td align="left" rowspan="1" colspan="1">&#x02212;58</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior parietal lobule</td><td align="left" rowspan="1" colspan="1">Brodmann area 7</td></tr><tr><td align="left" rowspan="1" colspan="1">4.55</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">&#x02212;4</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Middle frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 6</td></tr><tr><td align="left" rowspan="1" colspan="1">4.35</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Caudate</td><td align="left" rowspan="1" colspan="1">Caudate Head</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>RMET minus gender group mean</bold></italic></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">4.3</td><td align="left" rowspan="1" colspan="1">&#x02212;58</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 45</td></tr><tr><td align="left" rowspan="1" colspan="1">4.14</td><td align="left" rowspan="1" colspan="1">&#x02212;48</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">&#x02212;161</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 38</td></tr><tr><td align="left" rowspan="1" colspan="1">4.11</td><td align="left" rowspan="1" colspan="1">&#x02212;40</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 47</td></tr><tr><td align="left" rowspan="1" colspan="1">4.04</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Caudate</td><td align="left" rowspan="1" colspan="1">Caudate head</td></tr><tr><td align="left" rowspan="1" colspan="1">2.3</td><td align="left" rowspan="1" colspan="1">&#x02212;14</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">&#x02212;22</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Anterior cingulate gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 25</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>DIRECT COMPARISONS BETWEEN INTRA-NASAL OXYTOCIN AND PLACEBO</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Healthy matched controls <italic>n</italic>&#x02009;=&#x02009;9</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>RMET healthy oxytocin</bold></italic>&#x02009;&#x0003e;&#x02009;<bold><italic>placebo t-test</italic></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3.93</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">&#x02212;8</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Caudate</td><td align="left" rowspan="1" colspan="1">Caudate head</td></tr><tr><td align="left" rowspan="1" colspan="1">3.82</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">&#x02212;4</td><td align="left" rowspan="1" colspan="1">&#x02212;20</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Parahippocampal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 34</td></tr><tr><td align="left" rowspan="1" colspan="1">2.66</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">&#x02212;2</td><td align="left" rowspan="1" colspan="1">&#x02212;22</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Amygdala</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3.73</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">&#x02212;18</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 47</td></tr><tr><td align="left" rowspan="1" colspan="1">3.72</td><td align="left" rowspan="1" colspan="1">&#x02212;8</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Lentiform nucleus</td><td align="left" rowspan="1" colspan="1">*</td></tr><tr><td align="left" rowspan="1" colspan="1">3.67</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Anterior cingulate</td><td align="left" rowspan="1" colspan="1">Brodmann area 24</td></tr><tr><td align="left" rowspan="1" colspan="1">3.67</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">&#x02212;24</td><td align="left" rowspan="1" colspan="1">&#x02212;24</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Parahippocampal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 35</td></tr><tr><td align="left" rowspan="1" colspan="1">4.24</td><td align="left" rowspan="1" colspan="1">&#x02212;40</td><td align="left" rowspan="1" colspan="1">&#x02212;30</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Caudate</td><td align="left" rowspan="1" colspan="1">Caudate tail</td></tr><tr><td align="left" rowspan="1" colspan="1">3.94</td><td align="left" rowspan="1" colspan="1">&#x02212;50</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">&#x02212;18</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 38</td></tr><tr><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">&#x02212;56</td><td align="left" rowspan="1" colspan="1">&#x02212;8</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 22</td></tr><tr><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">&#x02212;4</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">&#x02212;12</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Anterior cingulate gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 25</td></tr><tr><td align="left" rowspan="1" colspan="1">2.69</td><td align="left" rowspan="1" colspan="1">&#x02212;4</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">&#x02212;14</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Anterior cingulate gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 32</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>Gender healthy oxytocin</bold></italic>&#x02009;&#x0003e;&#x02009;<bold><italic>placebo t-test</italic></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">No significant differences</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>Motor healthy oxytocin</bold></italic>&#x02009;&#x0003e;&#x02009;<bold><italic>placebo t-test</italic></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3.99</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">&#x02212;27</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 41</td></tr><tr><td align="left" rowspan="1" colspan="1">3.76</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">&#x02212;30</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Right cerebellum</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3.72</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">&#x02212;21</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 42</td></tr><tr><td align="left" rowspan="1" colspan="1">3.65</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">&#x02212;31</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 41</td></tr><tr><td align="left" rowspan="1" colspan="1">3.62</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">&#x02212;23</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Transverse temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 41</td></tr><tr><td align="left" rowspan="1" colspan="1">3.62</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">&#x02212;30</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 41</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Depressed unmedicated <italic>n</italic>&#x02009;=&#x02009;8</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>RMET depressed oxytocin</bold></italic>&#x02009;&#x0003e;&#x02009;<bold><italic>placebo t-test</italic></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3.99</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">&#x02212;20</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 38</td></tr><tr><td align="left" rowspan="1" colspan="1">3.79</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Insula</td><td align="left" rowspan="1" colspan="1">Brodmann area 13</td></tr><tr><td align="left" rowspan="1" colspan="1">3.77</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Precentral gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 44</td></tr><tr><td align="left" rowspan="1" colspan="1">3.73</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">&#x02212;14</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Inferior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 47</td></tr><tr><td align="left" rowspan="1" colspan="1">3.71</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">&#x02212;10</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 22</td></tr><tr><td align="left" rowspan="1" colspan="1">3.76</td><td align="left" rowspan="1" colspan="1">&#x02212;4</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Anterior cingulate</td><td align="left" rowspan="1" colspan="1">Brodmann area 24</td></tr><tr><td align="left" rowspan="1" colspan="1">3.75</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Cingulate gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 32</td></tr><tr><td align="left" rowspan="1" colspan="1">3.72</td><td align="left" rowspan="1" colspan="1">&#x02212;4</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Anterior cingulate</td><td align="left" rowspan="1" colspan="1">Brodmann area 32</td></tr><tr><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Medial frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 6</td></tr><tr><td align="left" rowspan="1" colspan="1">3.73</td><td align="left" rowspan="1" colspan="1">&#x02212;56</td><td align="left" rowspan="1" colspan="1">&#x02212;30</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 41</td></tr><tr><td align="left" rowspan="1" colspan="1">3.73</td><td align="left" rowspan="1" colspan="1">&#x02212;64</td><td align="left" rowspan="1" colspan="1">&#x02212;52</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 22</td></tr><tr><td align="left" rowspan="1" colspan="1">3.69</td><td align="left" rowspan="1" colspan="1">&#x02212;58</td><td align="left" rowspan="1" colspan="1">&#x02212;48</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Supramarginal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 40</td></tr><tr><td align="left" rowspan="1" colspan="1">3.65</td><td align="left" rowspan="1" colspan="1">&#x02212;52</td><td align="left" rowspan="1" colspan="1">&#x02212;32</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior temporal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 22</td></tr><tr><td align="left" rowspan="1" colspan="1">3.54</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">&#x02212;6</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 10</td></tr><tr><td align="left" rowspan="1" colspan="1">3.52</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Middle frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 9</td></tr><tr><td align="left" rowspan="1" colspan="1">3.41</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Middle frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 8</td></tr><tr><td align="left" rowspan="1" colspan="1">3.35</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Middle frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 10</td></tr><tr><td align="left" rowspan="1" colspan="1">3.33</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 9</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>RMET minus gender depressed oxytocin</bold></italic>&#x02009;&#x0003e;&#x02009;<bold><italic>placebo t-test</italic></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">No significant differences</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>Gender depressed oxytocin</bold></italic>&#x02009;&#x0003e;&#x02009;<bold><italic>placebo t-test</italic></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">No significant differences</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic><bold>Motor depressed oxytocin</bold></italic>&#x02009;&#x0003e;&#x02009;<bold><italic>placebo t-test</italic></bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3.51</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Medial frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 9</td></tr><tr><td align="left" rowspan="1" colspan="1">3.41</td><td align="left" rowspan="1" colspan="1">&#x02212;18</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 9</td></tr><tr><td align="left" rowspan="1" colspan="1">3.39</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Medial frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 8</td></tr><tr><td align="left" rowspan="1" colspan="1">3.44</td><td align="left" rowspan="1" colspan="1">&#x02212;2</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Medial frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 8</td></tr><tr><td align="left" rowspan="1" colspan="1">3.47</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Medial frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 6</td></tr><tr><td align="left" rowspan="1" colspan="1">3.59</td><td align="left" rowspan="1" colspan="1">&#x02212;2</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">Left</td><td align="left" rowspan="1" colspan="1">Superior frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 6</td></tr><tr><td align="left" rowspan="1" colspan="1">3.6</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">Right</td><td align="left" rowspan="1" colspan="1">Medial frontal gyrus</td><td align="left" rowspan="1" colspan="1">Brodmann area 6</td></tr></tbody></table></table-wrap><sec><title>Baseline mean groups</title><p>During the RMET task, at baseline and prior to inhaling study drug, depressed and normal control subjects showed statistically significant activations of the visual cortex, associated visual areas, the fusiform gyrus, and various limbic areas, along with the anterior cingulate. The depressed group showed significant activation in the right anterior cingulate gyrus (BA32), insula and middle frontal gyrus (BA6), left superior parietal lobe (BA7) and head of the caudate. The two groups were not significantly different in intensities or areas of activation on the mentalization task. They did however differ when contrasting RMET minus gender identification (see Figure <xref ref-type="fig" rid="F2">2</xref>). The depressed group showed predominantly ventral activations with left inferior frontal gyrus, superior temporal gyrus, subgenual cingulum and head of the caudate. The healthy controls showed activations in the superior and middle frontal gyri, the orbito-frontal cortex and middle temporal gyrus (BA21, 22).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Baseline RMET minus Gender Attribution: Predominant ventral activations in unmedicated depressed subjects at baseline (red) compared to superior frontal and temporal activations in healthy matched controls (blue)</bold>.</p></caption><graphic xlink:href="fpsyt-01-00134-g002"/></fig></sec><sec><title>Oxytocin versus placebo</title><sec><title>Depressed group</title><p>During RMET, there was significant activation with oxytocin compared to placebo in bilateral superior temporal gyrus (BA38, 41, and 22), right insula, right precentral gyrus (BA44), bilateral cingulate gyri (BA32), left anterior cingulum (BA24), left supramarginal gyrus (BA40), right inferior frontal gyrus (BA47), right superior and middle frontal gyri (BA8, 9, and 10) (see Figure <xref ref-type="fig" rid="F3">3</xref>). On motor cues, oxytocin led to significant increases in bilateral superior and medial frontal gyri (BA6, 8 and 9). Gender identifications and RMET minus gender identifications did not differ between oxytocin and placebo conditions.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Baseline (green) and added activations with oxytocin compared to placebo (red) in unmedicated depressed subjects during RMET</bold>.</p></caption><graphic xlink:href="fpsyt-01-00134-g003"/></fig></sec><sec><title>Matched healthy controls</title><p>During RMET, there was significant activation with oxytocin compared to placebo in right parahippocampal gyrus extending to the amygdala, inferior frontal gyrus (BA47), left head and tail of the caudate and superior temporal gyrus (BA22 and 38) (see Figure <xref ref-type="fig" rid="F4">4</xref>). On Motor Cues, oxytocin led to significant increases in right superior temporal gyrus (BA41 and 42) and right cerebellum. Gender identifications and RMET minus gender identifications did not differ between oxytocin and placebo conditions.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Baseline (green) and added activations with oxytocin compared to placebo (red) in healthy matched controls during RMET</bold>.</p></caption><graphic xlink:href="fpsyt-01-00134-g004"/></fig></sec></sec></sec></sec><sec><title>Discussion</title><p>To our knowledge, this is the first study investigating intra-nasal oxytocin in unmedicated depressed and matched controls using fMRI. We employed RMET, a visual perceptual task that involves more affectively valenced decision making and mental attributions of other people. The task emphasizes affective &#x0201c;involvement&#x0201d; rather than cognitive &#x0201c;appraisal.&#x0201d; At baseline, the two groups were significantly different in their distress symptoms and capacity to empathize. Along with activating attentional and visual networks, RMET also involved anterior ventromedial regions. Oxytocin differentially affected normal and depressed cohorts. In controls, oxytocin enhanced activation of ventromedial, amygdala, parahippocampal and semantic associative areas. Depressed subjects showed increases in higher order cognitive areas and insula. Oxytocin also showed opposite effects in reaction times with increased speed of response in healthy controls and a slowing among the depressed.</p><sec><title>Mentalizing in depression</title><p>The mentalization task is a novel paradigm in this population. It is relatively complex and recruits several complementary limbic, attention and high-level executive networks. Pathological states such as depression degrade mentalization (Uekermann et al., <xref ref-type="bibr" rid="B47">2008</xref>), perhaps by limiting emotional involvement with all things and people in their experiential world and reflection upon their internal world, functioning more in a purely cognitively appraised, distant or disconnected fashion. The results reported here suggest that depression may represent a homeostatic alteration in contributions of these systems to executing this task compared to healthy controls. Many of the findings we report are in line with abundant existing evidence of limbic and executive dysfunction in depression (Green et al., <xref ref-type="bibr" rid="B16">2007</xref>; Northoff, <xref ref-type="bibr" rid="B35">2007</xref>). The distinct increase in ventro-limbic activity is also reminiscent of mood induction studies (George et al., <xref ref-type="bibr" rid="B15">1995</xref>; Mayberg et al., <xref ref-type="bibr" rid="B29">1999</xref>). But the direct consequences of such dysregulation in not clear since behavioral performance on RMET in depressed patients was not significantly different from controls and did not appear biased towards negative affect. The task itself may not be difficult enough to tease out such biases (Domes et al., <xref ref-type="bibr" rid="B10">2007</xref>). Whether these differences in functional activity are associated with state or trait markers also remains unclear.</p><p>Although we did not see any significant difference between groups with RMET contrast, we did find higher anterior subgenual cingulate activation and anterior temporal pole during RMET minus gender attribution in depressed, suggesting that mentalization preferentially linked processing of perceptual inputs to internal visceral emotional experiences (Figure <xref ref-type="fig" rid="F2">2</xref>). This contrasts with activations of anterior frontal pole, supramotor and working memory areas in healthy controls. Note that both groups exhibited activations of semantic and word processing regions but there too, activity was more restricted to the inferior frontal gyrus in depressed patients. These finding, along with a relatively faster reaction times in depressed patients, suggests that this cohort mentalized in a more primary, impulsive way, whereas in healthy controls the task engaged a more distributed network that involved higher order abstract cognitive and emotional integrative regions (Petrides and Pandya, <xref ref-type="bibr" rid="B38">2007</xref>).</p></sec><sec><title>The effects of oxytocin on mentalization</title><p>Our fMRI data reveals that intra-nasal oxytocin has a differential effect upon the brain of depressed and normal people, as if in the state of depression, oxytocin &#x0201c;recruits&#x0201d; a more emotionally reflexive appraisal state that is less affectively reflective. Oxytocin increased primarily emotional circuits as in the cingulate (BA24) and insula in depressed patients during RMET. These increases appear to be in the same general directions as baseline activation patterns (Figure <xref ref-type="fig" rid="F3">3</xref>). Conversely, oxytocin increased ventral activity in healthy controls adding a different and substantial &#x0201c;primary affective appraisal&#x0201d; regional component (amygdala, parahippocampus) along with social appraisal (BA25 and 32) to baseline activation pattern (Figure <xref ref-type="fig" rid="F4">4</xref>). This is in contrast with reports of reduced activation of the amygdala in response to fear-inducing visual stimuli coupled with oxytocin inhalation (Kirsch et al., <xref ref-type="bibr" rid="B26">2005</xref>). Oxytocin also moderately decreased the reaction time in healthy controls. This is in line with reports of oxytocin improving RMET in healthy individuals when analyses focused on the more complex and difficult items (Domes et al., <xref ref-type="bibr" rid="B10">2007</xref>), In contrasts, depressed patients remained faster at their responses than controls but tended to show a more deliberative response to the situations. Oxytocin did not alter the accuracy of responses in either group.</p></sec><sec><title>Limitations</title><p>Number of subjects is relatively small although the total scans analyzed is 80. Individual variability and total sample size cannot identify main responders. The exclusion of one male subject in healthy controls did not significantly change the results. The effect size on behavioral response (RT) is small and perhaps due to relatively small single dose of oxytocin and the intra-nasal route. Added to this are the small size of the olfactory nasal mucosa, the small instillation volume and the relatively fast turnover of cerebrospinal fluid which will render the total amount of active oxytocin that reached the brain small (Pontiroli, <xref ref-type="bibr" rid="B40">1998</xref>; Petrides and Pandya, <xref ref-type="bibr" rid="B38">2007</xref>). Oxytocin is also known to gradually degrade into several metabolites that may reduce the potency of the preparation (Claybaugh and Uyehara, <xref ref-type="bibr" rid="B7">1993</xref>; Burbach et al., <xref ref-type="bibr" rid="B5">1998</xref>). The effect size on RT may have been influenced by the relative simple to moderate difficulty in the RMET images themselves which may limited the range of improvement after oxytocin inhalation (Domes et al., <xref ref-type="bibr" rid="B10">2007</xref>).</p><p>In summary, we have shown that depressed subjects perform a mental attribution task differently than healthy matched controls. In addition, a single dose of intra-nasal oxytocin has distinct effects on functional activity of networks involved in a mental attribution task and enhances cognitive and emotional appraisal. These effects appear to be dependent on the distress levels of individuals, their likely capacity to empathize and the underlying homeostasis of the affective primary brain processes. It is not clear from our study what role, if any, oxytocin may have in modulating and perhaps treating depressive symptoms. Other studies of this important component of depressive pathology are needed with likely longer exposure and repeated oxytocin administration.</p></sec></sec><sec><title>Conflict of Interest Statement</title><p> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>Study funded by the Hope for Depression Research Foundation (ZN). Study was also made possible with general funds from NIMH 1K08MH70615-01A1 (ZN), the Mood Disorders Program, the Brain Stimulation Laboratory, the Center for Advanced Imaging Research at the Medical University of South Carolina (MUSC). The authors would like to thank Lee-Silsby Pharmacy in Cleveland, Ohio for providing the intra-nasal oxytocin and matching placebo, Kimberly Porter, Rph at MUSC Investigational Drug Services for randomization and dispensing drug, and the South Carolina Research Authority in Charleston, South Carolina for imaging storage and support.</p></ack><fn-group><fn id="fn1"><p><sup>1</sup>http://www.sph.sc.edu/comd/rorden/mricro.html</p></fn><fn id="fn2"><p><sup>2</sup>www.fmrib.ox.ac.uk/fsl</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Anisman</surname><given-names>H.</given-names></name></person-group> (<year>1984</year>). <article-title>&#x0201c;Vulnerability to depression: contribution of stress,&#x0201d;</article-title>
<source>in Neurobiology of Mood Disorders</source> eds<person-group person-group-type="editor"><name><surname>R. M. Post</surname><given-names>R. M.</given-names></name><name><surname>Ballenger</surname><given-names>J. C.</given-names></name></person-group>(<publisher-loc>Baltimore</publisher-loc>: <publisher-name>Williams and Wilkins</publisher-name>), <fpage>407</fpage>&#x02013;<lpage>431</lpage></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name><name><surname>Ring</surname><given-names>H.</given-names></name><name><surname>Chitnis</surname><given-names>X.</given-names></name><name><surname>Wheelwright</surname><given-names>S.</given-names></name><name><surname>Gregory</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>S.</given-names></name><name><surname>Brammer</surname><given-names>M.</given-names></name><name><surname>Bullmore</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>fMRI of parents of children with Asperger syndrome: a pilot study</article-title>. <source>Brain Cogn.</source>
<volume>61</volume>, <fpage>122</fpage>&#x02013;<lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.bandc.2005.12.011</pub-id><pub-id pub-id-type="pmid">16460858</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name><name><surname>Wheelwright</surname><given-names>S.</given-names></name><name><surname>Hill</surname><given-names>J.</given-names></name><name><surname>Raste</surname><given-names>Y.</given-names></name><name><surname>Plumb</surname><given-names>I.</given-names></name></person-group> (<year>2001</year>). <article-title>The &#x0201c;Reading the Mind in the Eyes&#x0201d; test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism</article-title>. <source>J. Child. Psychol. Psychiatry</source>
<volume>42</volume>, <fpage>241</fpage>&#x02013;<lpage>251</lpage><pub-id pub-id-type="doi">10.1111/1469-7610.00715</pub-id><pub-id pub-id-type="pmid">11280420</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Plasma oxytocin levels in depression and their correlation with the temperament dimension of reward dependence</article-title>. <source>J. Psychopharmacol.</source>
<volume>20</volume>, <fpage>656</fpage>&#x02013;<lpage>660</lpage><pub-id pub-id-type="doi">10.1177/0269881106060512</pub-id><pub-id pub-id-type="pmid">16401658</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burbach</surname><given-names>J. P.</given-names></name><name><surname>Schoots</surname><given-names>O.</given-names></name><name><surname>Hernando</surname><given-names>F.</given-names></name></person-group> (<year>1998</year>). <article-title>Biochemistry of vasopressin fragments</article-title>. <source>Prog. Brain Res.</source>
<volume>119</volume>, <fpage>127</fpage>&#x02013;<lpage>136</lpage><pub-id pub-id-type="doi">10.1016/S0079-6123(08)61566-6</pub-id><pub-id pub-id-type="pmid">10074785</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi-Kain</surname><given-names>L. W.</given-names></name><name><surname>Gunderson</surname><given-names>J. G.</given-names></name></person-group> (<year>2008</year>). <article-title>Mentalization: ontogeny, assessment, and application in the treatment of borderline personality disorder</article-title>. <source>Am. J. Psychiatry</source>
<volume>165</volume>, <fpage>1127</fpage>&#x02013;<lpage>1135</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2008.07081360</pub-id><pub-id pub-id-type="pmid">18676591</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claybaugh</surname><given-names>J. R.</given-names></name><name><surname>Uyehara</surname><given-names>C. F.</given-names></name></person-group> (<year>1993</year>). <article-title>Metabolism of neurohypophysial hormones</article-title>. <source>Ann. N. Y. Acad. Sci.</source>
<volume>689</volume>, <fpage>250</fpage>&#x02013;<lpage>268</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1993.tb55552.x</pub-id><pub-id pub-id-type="pmid">8373016</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Leeuw</surname><given-names>J.</given-names></name><name><surname>Kreft</surname><given-names>I. G.</given-names></name></person-group> (<year>1995</year>). <article-title>Questioning multilevel models</article-title>. <source>J. Educ. Behav. Stat.</source>
<volume>20</volume>, <fpage>171</fpage>&#x02013;<lpage>189</lpage></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ditzen</surname><given-names>B.</given-names></name><name><surname>Neumann</surname><given-names>I. D.</given-names></name><name><surname>Bodenmann</surname><given-names>G.</given-names></name><name><surname>von Dawans</surname><given-names>B.</given-names></name><name><surname>Turner</surname><given-names>R. A.</given-names></name><name><surname>Ehlert</surname><given-names>U.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Effects of different kinds of couple interaction on cortisol and heart rate responses to stress in women</article-title>. <source>Psychoneuroendocrinology</source>
<volume>32</volume>, <fpage>565</fpage>&#x02013;<lpage>574</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2007.03.011</pub-id><pub-id pub-id-type="pmid">17499441</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domes</surname><given-names>G.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name><name><surname>Michel</surname><given-names>A.</given-names></name><name><surname>Berger</surname><given-names>C.</given-names></name><name><surname>Herpertz</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Oxytocin improves &#x0201c;mind-reading&#x0201d; in humans</article-title>. <source>Biol. Psychiatry</source>
<volume>61</volume>, <fpage>731</fpage>&#x02013;<lpage>733</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2006.07.015</pub-id><pub-id pub-id-type="pmid">17137561</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epperson</surname><given-names>C. N.</given-names></name><name><surname>McDougle</surname><given-names>C. J.</given-names></name><name><surname>Price</surname><given-names>L. H.</given-names></name></person-group> (<year>1996a</year>). <article-title>Intranasal oxytocin in obsessive-compulsive disorder</article-title>. <source>Biol. Psychiatry</source>
<volume>40</volume>, <fpage>547</fpage>&#x02013;<lpage>549</lpage><pub-id pub-id-type="doi">10.1016/0006-3223(96)00120-5</pub-id><pub-id pub-id-type="pmid">8879477</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epperson</surname><given-names>C. N.</given-names></name><name><surname>McDougle</surname><given-names>C. J.</given-names></name><name><surname>Price</surname><given-names>L. H.</given-names></name></person-group> (<year>1996b</year>). <article-title>Intranasal oxytocin in trichotillomania</article-title>. <source>Biol. Psychiatry</source>
<volume>40</volume>, <fpage>559</fpage>&#x02013;<lpage>560</lpage><pub-id pub-id-type="doi">10.1016/0006-3223(96)00165-5</pub-id><pub-id pub-id-type="pmid">8879481</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonagy</surname><given-names>P.</given-names></name><name><surname>Target</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>The rooting of the mind in the body: new links between attachment theory and psychoanalytic thought</article-title>. <source>J. Am. Psychoanal. Assoc.</source>
<volume>55</volume>, <fpage>411</fpage>&#x02013;<lpage>456</lpage><pub-id pub-id-type="pmid">17601099</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>H. L.</given-names></name><name><surname>Happe</surname><given-names>F.</given-names></name><name><surname>Brunswick</surname><given-names>N.</given-names></name><name><surname>Fletcher</surname><given-names>P. C.</given-names></name><name><surname>Frith</surname><given-names>U.</given-names></name><name><surname>Frith</surname><given-names>C. D.</given-names></name></person-group> (<year>2000</year>). <article-title>Reading the mind in cartoons and stories: an fMRI study of &#x02018;theory of mind&#x02019; in verbal and nonverbal tasks</article-title>. <source>Neuropsychologia</source>
<volume>38</volume>, <fpage>11</fpage>&#x02013;<lpage>21</lpage><pub-id pub-id-type="doi">10.1016/S0028-3932(99)00053-6</pub-id><pub-id pub-id-type="pmid">10617288</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>George</surname><given-names>M. S.</given-names></name><name><surname>Kimbrell</surname><given-names>T. A.</given-names></name><name><surname>Parekh</surname><given-names>P. I.</given-names></name><name><surname>Ketter</surname><given-names>T. A.</given-names></name><name><surname>Pazzaglia</surname><given-names>P. J.</given-names></name><name><surname>Callahan</surname><given-names>A.</given-names></name><name><surname>Frye</surname><given-names>M.</given-names></name><name><surname>Marangell</surname><given-names>L.</given-names></name><name><surname>Herscovitch</surname><given-names>P.</given-names></name><name><surname>Post</surname><given-names>R. M.</given-names></name></person-group> (<year>1995</year>). <source>Actively Depressed Subjects Have Difficulty Inducing, and Blunted Limbic rCBF During, Transient Sadness</source>. <publisher-loc>Miami</publisher-loc>: <publisher-name>APA New Research</publisher-name> Abstracts 99-NR167.</mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>M. J.</given-names></name><name><surname>Cahill</surname><given-names>C. M.</given-names></name><name><surname>Malhi</surname><given-names>G. S.</given-names></name></person-group> (<year>2007</year>). <article-title>The cognitive and neurophysiological basis of emotion dysregulation in bipolar disorder</article-title>. <source>J. Affect. Disord.</source>
<volume>103</volume>, <fpage>29</fpage>&#x02013;<lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2007.01.024</pub-id><pub-id pub-id-type="pmid">17328959</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>A. J.</given-names></name><name><surname>Mitchell</surname><given-names>P. B.</given-names></name><name><surname>Dadds</surname><given-names>M. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Oxytocin increases gaze to the eye region of human faces</article-title>. <source>Biol. Psychiatry</source>
<volume>63</volume>, <fpage>3</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2007.06.026</pub-id><pub-id pub-id-type="pmid">17888410</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Happe</surname><given-names>F.</given-names></name><name><surname>Ehlers</surname><given-names>S.</given-names></name><name><surname>Fletcher</surname><given-names>P.</given-names></name><name><surname>Frith</surname><given-names>U.</given-names></name><name><surname>Johansson</surname><given-names>M.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Dolan</surname><given-names>R.</given-names></name><name><surname>Frackowiak</surname><given-names>R.</given-names></name><name><surname>Frith</surname><given-names>C.</given-names></name></person-group> (<year>1996</year>). <article-title>&#x02018;Theory of mind&#x02019; in the brain. Evidence from a PET scan study of Asperger syndrome</article-title>. <source>Neuroreport</source>
<volume>8</volume>, <fpage>197</fpage>&#x02013;<lpage>201</lpage><pub-id pub-id-type="doi">10.1097/00001756-199612200-00040</pub-id><pub-id pub-id-type="pmid">9051780</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Happe</surname><given-names>F. G.</given-names></name></person-group> (<year>1994</year>). <article-title>An advanced test of theory of mind: understanding of story characters&#x02019; thoughts and feelings by able autistic, mentally handicapped, and normal children and adults</article-title>. <source>J. Autism Dev. Disord.</source>
<volume>24</volume>, <fpage>129</fpage>&#x02013;<lpage>154</lpage><pub-id pub-id-type="doi">10.1007/BF02172093</pub-id><pub-id pub-id-type="pmid">8040158</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>H. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Psychoanalytic self psychology and its conceptual development in light of developmental psychology, attachment theory, and neuroscience</article-title>. <source>Ann. N. Y. Acad. Sci.</source>
<volume>1159</volume>, <fpage>86</fpage>&#x02013;<lpage>105</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.04476.x</pub-id><pub-id pub-id-type="pmid">19379234</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>D. A.</given-names></name><name><surname>Gavin</surname><given-names>M. B.</given-names></name></person-group> (<year>1998</year>). <article-title>Centering decisions in hierarchical linear models: implications for research in organizations</article-title>. <source>J. Manage.</source>
<volume>24</volume>, <fpage>623</fpage>&#x02013;<lpage>641</lpage></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurlemann</surname><given-names>R.</given-names></name><name><surname>Patin</surname><given-names>A.</given-names></name><name><surname>Onur</surname><given-names>O. A.</given-names></name><name><surname>Cohen</surname><given-names>M. X.</given-names></name><name><surname>Baumgartner</surname><given-names>T.</given-names></name><name><surname>Metzler</surname><given-names>S.</given-names></name><name><surname>Dziobek</surname><given-names>I.</given-names></name><name><surname>Gallinat</surname><given-names>J.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Kendrick</surname><given-names>K. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans</article-title>. <source>J. Neurosci.</source>
<volume>30</volume>, <fpage>4999</fpage>&#x02013;<lpage>5007</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5538-09.2010</pub-id><pub-id pub-id-type="pmid">20371820</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>M.</given-names></name><name><surname>Bannister</surname><given-names>P.</given-names></name><name><surname>Brady</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Improved optimization for the robust and accurate linear registration and motion correction of brain images</article-title>. <source>Neuroimage</source>
<volume>17</volume>, <fpage>825</fpage>&#x02013;<lpage>841</lpage><pub-id pub-id-type="doi">10.1016/S1053-8119(02)91132-8</pub-id><pub-id pub-id-type="pmid">12377157</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>A global optimisation method for robust affine registration of brain images</article-title>. <source>Med. Image Anal.</source>
<volume>5</volume>, <fpage>143</fpage>&#x02013;<lpage>156</lpage><pub-id pub-id-type="doi">10.1016/S1361-8415(01)00036-6</pub-id><pub-id pub-id-type="pmid">11516708</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>P. J.</given-names></name><name><surname>Stojanov</surname><given-names>W.</given-names></name><name><surname>Devir</surname><given-names>H.</given-names></name><name><surname>Schall</surname><given-names>U.</given-names></name></person-group> (<year>2005</year>). <article-title>Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates</article-title>. <source>Eur. J. Neurosci.</source>
<volume>22</volume>, <fpage>1221</fpage>&#x02013;<lpage>1232</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04294.x</pub-id><pub-id pub-id-type="pmid">16176365</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirsch</surname><given-names>P.</given-names></name><name><surname>Esslinger</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Mier</surname><given-names>D.</given-names></name><name><surname>Lis</surname><given-names>S.</given-names></name><name><surname>Siddhanti</surname><given-names>S.</given-names></name><name><surname>Gruppe</surname><given-names>H.</given-names></name><name><surname>Mattay</surname><given-names>V. S.</given-names></name><name><surname>Gallhofer</surname><given-names>B.</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Oxytocin modulates neural circuitry for social cognition and fear in humans</article-title>. <source>J. Neurosci.</source>
<volume>25</volume>, <fpage>11489</fpage>&#x02013;<lpage>11493</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3984-05.2005</pub-id><pub-id pub-id-type="pmid">16339042</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>M.</given-names></name><name><surname>Mohler</surname><given-names>B.</given-names></name><name><surname>Raudenbush</surname><given-names>S. L.</given-names></name><name><surname>Earls</surname><given-names>F. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Assessing exposure to violence using multiple informants: application of hierarchical linear model</article-title>. <source>J. Child. Psychol. Psychiatry</source>
<volume>41</volume>, <fpage>1049</fpage>&#x02013;<lpage>1056</lpage><pub-id pub-id-type="doi">10.1111/1469-7610.00692</pub-id><pub-id pub-id-type="pmid">11099121</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>A. A.</given-names></name><name><surname>Yu</surname><given-names>H. H.</given-names></name><name><surname>Pine</surname><given-names>D. S.</given-names></name><name><surname>Blair</surname><given-names>R. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxytocin improves specific recognition of positive facial expressions</article-title>. <source>Psychopharmacology (Berl)</source>
<volume>209</volume>, <fpage>225</fpage>&#x02013;<lpage>232</lpage><pub-id pub-id-type="doi">10.1007/s00213-010-1780-4</pub-id><pub-id pub-id-type="pmid">20186397</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayberg</surname><given-names>H. S.</given-names></name><name><surname>Liotti</surname><given-names>M.</given-names></name><name><surname>Brannan</surname><given-names>S. K.</given-names></name><name><surname>McGinnis</surname><given-names>S.</given-names></name><name><surname>Mahurin</surname><given-names>R. K.</given-names></name><name><surname>Jerabek</surname><given-names>P. A.</given-names></name><name><surname>Silva</surname><given-names>J. A.</given-names></name><name><surname>Tekell</surname><given-names>J. L.</given-names></name><name><surname>Martin</surname><given-names>C. C.</given-names></name><name><surname>Lancaster</surname><given-names>J. L.</given-names></name><name><surname>Fox</surname><given-names>P. T.</given-names></name></person-group> (<year>1999</year>). <article-title>Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness</article-title>. <source>Am. J Psychiatry</source>
<volume>156</volume>, <fpage>675</fpage>&#x02013;<lpage>682</lpage><pub-id pub-id-type="pmid">10327898</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>J. D.</given-names></name><name><surname>Salovey</surname><given-names>P.</given-names></name><name><surname>Caruso</surname><given-names>D. R.</given-names></name><name><surname>Sitarenios</surname><given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>Measuring emotional intelligence with the MSCEIT V2</article-title>.0<source>. Emotion</source>
<volume>3</volume>, <fpage>97</fpage>&#x02013;<lpage>105</lpage><pub-id pub-id-type="doi">10.1037/1528-3542.3.1.97</pub-id><pub-id pub-id-type="pmid">12899321</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuigan</surname><given-names>W. M.</given-names></name><name><surname>Katzev</surname><given-names>A. R.</given-names></name><name><surname>Pratt</surname><given-names>C. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Multi-level determinants of retention in a home-visiting child abuse prevention program</article-title>. <source>Child Abuse Negl.</source>
<volume>27</volume>, <fpage>363</fpage>&#x02013;<lpage>380</lpage><pub-id pub-id-type="doi">10.1016/S0145-2134(03)00024-3</pub-id><pub-id pub-id-type="pmid">12686322</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meins</surname><given-names>E.</given-names></name><name><surname>Fernyhough</surname><given-names>C.</given-names></name><name><surname>Wainwright</surname><given-names>R.</given-names></name><name><surname>Das Gupta</surname><given-names>M.</given-names></name><name><surname>Fradley</surname><given-names>E.</given-names></name><name><surname>Tuckey</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Maternal mind-mindedness and attachment security as predictors of theory of mind understanding</article-title>. <source>Child Dev.</source>
<volume>73</volume>, <fpage>1715</fpage>&#x02013;<lpage>1726</lpage><pub-id pub-id-type="doi">10.1111/1467-8624.00501</pub-id><pub-id pub-id-type="pmid">12487489</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>E. E.</given-names></name><name><surname>Panksepp</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine</article-title>. <source>Neurosci. Biobehav. Rev.</source>
<volume>22</volume>, <fpage>437</fpage>&#x02013;<lpage>452</lpage><pub-id pub-id-type="doi">10.1016/S0149-7634(97)00052-3</pub-id><pub-id pub-id-type="pmid">9579331</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nezlek</surname><given-names>J. B.</given-names></name><name><surname>Zyzniewski</surname><given-names>L. E.</given-names></name></person-group> (<year>1998</year>). <article-title>Using hierarchical linear modeling to analyze grouped data</article-title>. <source>Grouped Dyn.</source>
<volume>2</volume>, <fpage>313</fpage>&#x02013;<lpage>320</lpage><pub-id pub-id-type="doi">10.1037/1089-2699.2.4.313</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northoff</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Psychopathology and pathophysiology of the self in depression &#x02013; neuropsychiatric hypothesis</article-title>. <source>J. Affect. Disord.</source>
<volume>104</volume>, <fpage>1</fpage>&#x02013;<lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2007.02.012</pub-id><pub-id pub-id-type="pmid">17379318</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozonoff</surname><given-names>S.</given-names></name><name><surname>Pennington</surname><given-names>B. F.</given-names></name><name><surname>Rogers</surname><given-names>S. J.</given-names></name></person-group> (<year>1991</year>). <article-title>Executive function deficits in high-functioning autistic individuals: relationship to theory of mind</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>32</volume>, <fpage>1081</fpage>&#x02013;<lpage>1105</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7610.1991.tb00351.x</pub-id><pub-id pub-id-type="pmid">1787138</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panksepp</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Affective consciousness: core emotional feelings in animals and humans</article-title>. <source>Conscious. Cogn.</source>
<volume>14</volume>, <fpage>30</fpage>&#x02013;<lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.concog.2004.10.004</pub-id><pub-id pub-id-type="pmid">15766890</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrides</surname><given-names>M.</given-names></name><name><surname>Pandya</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Efferent association pathways from the rostral prefrontal cortex in the macaque monkey</article-title>. <source>J. Neurosci.</source>
<volume>27</volume>, <fpage>11573</fpage>&#x02013;<lpage>11586</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2419-07.2007</pub-id><pub-id pub-id-type="pmid">17959800</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilowsky</surname><given-names>T.</given-names></name><name><surname>Yirmiya</surname><given-names>N.</given-names></name><name><surname>Arbelle</surname><given-names>S.</given-names></name><name><surname>Mozes</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>Theory of mind abilities of children with schizophrenia, children with autism, and normally developing children</article-title>. <source>Schizophr. Res.</source>
<volume>42</volume>, <fpage>145</fpage>&#x02013;<lpage>155</lpage><pub-id pub-id-type="doi">10.1016/S0920-9964(99)00101-2</pub-id><pub-id pub-id-type="pmid">10742652</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pontiroli</surname><given-names>A. E.</given-names></name></person-group> (<year>1998</year>). <article-title>Peptide hormones: review of current and emerging uses by nasal delivery</article-title>. <source>Adv. Drug Deliv. Rev.</source>
<volume>29</volume>, <fpage>81</fpage>&#x02013;<lpage>87</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(97)00062-8</pub-id><pub-id pub-id-type="pmid">10837581</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>J. L.</given-names></name><name><surname>Drevets</surname><given-names>W. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Neurocircuitry of mood disorders</article-title>. <source>Neuropsychopharmacology</source>
<volume>35</volume>, <fpage>192</fpage>&#x02013;<lpage>216</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.104</pub-id><pub-id pub-id-type="pmid">19693001</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raudenbush</surname><given-names>S. W.</given-names></name><name><surname>Chan</surname><given-names>W. S.</given-names></name></person-group> (<year>1993</year>). <article-title>Application of a hierarchical linear model to the study of adolescent deviance in an overlapping cohort design</article-title>. <source>J. Consult. Clin. Psychol.</source>
<volume>61</volume>, <fpage>941</fpage>&#x02013;<lpage>951</lpage><pub-id pub-id-type="doi">10.1037/0022-006X.61.6.941</pub-id><pub-id pub-id-type="pmid">8113495</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzolatti</surname><given-names>G.</given-names></name><name><surname>Fabbri-Destro</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>The mirror system and its role in social cognition</article-title>. <source>Curr. Opin. Neurobiol.</source>
<volume>18</volume>, <fpage>179</fpage>&#x02013;<lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2008.08.001</pub-id><pub-id pub-id-type="pmid">18706501</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sliwinski</surname><given-names>M. J.</given-names></name><name><surname>Hall</surname><given-names>C. B.</given-names></name></person-group> (<year>1998</year>). <article-title>Constraints on general slowing: a meta-analysis using hierarchical linear models with random coefficients</article-title>. <source>Psychol. Aging</source>
<volume>13</volume>, <fpage>164</fpage>&#x02013;<lpage>175</lpage><pub-id pub-id-type="doi">10.1037/0882-7974.13.1.164</pub-id><pub-id pub-id-type="pmid">9533199</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Fast robust automated brain extraction</article-title>. <source>Hum. Brain Mapp.</source>
<volume>17</volume>, <fpage>143</fpage>&#x02013;<lpage>155</lpage><pub-id pub-id-type="doi">10.1002/hbm.10062</pub-id><pub-id pub-id-type="pmid">12391568</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuss</surname><given-names>D. T.</given-names></name><name><surname>Gallup</surname><given-names>G. G. Jr.</given-names></name><name><surname>Alexander</surname><given-names>M. P.</given-names></name></person-group> (<year>2001</year>). <article-title>The frontal lobes are necessary for &#x02018;theory of mind&#x02019;</article-title>. <source>Brain</source>
<volume>124</volume>, <fpage>279</fpage>&#x02013;<lpage>286</lpage><pub-id pub-id-type="doi">10.1093/brain/124.2.279</pub-id><pub-id pub-id-type="pmid">11157555</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uekermann</surname><given-names>J.</given-names></name><name><surname>Channon</surname><given-names>S.</given-names></name><name><surname>Lehmkamper</surname><given-names>C.</given-names></name><name><surname>Abdel-Hamid</surname><given-names>M.</given-names></name><name><surname>Vollmoeller</surname><given-names>W.</given-names></name><name><surname>Daum</surname><given-names>I.</given-names></name></person-group> (<year>2008</year>). <article-title>Executive function, mentalizing and humor in major depression</article-title>. <source>J. Int. Neuropsychol. Soc.</source>
<volume>14</volume>, <fpage>55</fpage>&#x02013;<lpage>62</lpage><pub-id pub-id-type="doi">10.1017/S1355617708080016</pub-id><pub-id pub-id-type="pmid">18078531</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uvnas-Moberg</surname><given-names>K.</given-names></name></person-group> (<year>1998</year>). <article-title>Oxytocin may mediate the benefits of positive social interaction and emotions</article-title>. <source>Psychoneuroendocrinology</source>
<volume>23</volume>, <fpage>819</fpage>&#x02013;<lpage>835</lpage><pub-id pub-id-type="doi">10.1016/S0306-4530(98)00056-0</pub-id><pub-id pub-id-type="pmid">9924739</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogeley</surname><given-names>K.</given-names></name><name><surname>Bussfeld</surname><given-names>P.</given-names></name><name><surname>Newen</surname><given-names>A.</given-names></name><name><surname>Herrmann</surname><given-names>S.</given-names></name><name><surname>Happe</surname><given-names>F.</given-names></name><name><surname>Falkai</surname><given-names>P.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Shah</surname><given-names>N. J.</given-names></name><name><surname>Fink</surname><given-names>G. R.</given-names></name><name><surname>Zilles</surname><given-names>K.</given-names></name></person-group> (<year>2001a</year>). <article-title>Mind reading: neural mechanisms of theory of mind and self-perspective</article-title>. <source>Neuroimage</source>
<volume>14</volume>, <fpage>170</fpage>&#x02013;<lpage>181</lpage><pub-id pub-id-type="doi">10.1006/nimg.2001.0789</pub-id><pub-id pub-id-type="pmid">11525326</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogeley</surname><given-names>K.</given-names></name><name><surname>Bussfeld</surname><given-names>P.</given-names></name><name><surname>Newen</surname><given-names>A.</given-names></name><name><surname>Herrmann</surname><given-names>S.</given-names></name><name><surname>Happe</surname><given-names>F.</given-names></name><name><surname>Falkai</surname><given-names>P.</given-names></name><name><surname>Maier</surname><given-names>W.</given-names></name><name><surname>Shah</surname><given-names>N. J.</given-names></name><name><surname>Fink</surname><given-names>G. R.</given-names></name><name><surname>Zilles</surname><given-names>K.</given-names></name></person-group> (<year>2001b</year>). <article-title>Mind reading: neural mechanisms of theory of mind and self-perspective</article-title>. <source>Neuroimage</source>
<volume>14</volume>, <fpage>170</fpage>&#x02013;<lpage>181</lpage><pub-id pub-id-type="doi">10.1006/nimg.2001.0789</pub-id><pub-id pub-id-type="pmid">11525326</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>J. G.</given-names></name><name><surname>Allison</surname><given-names>C.</given-names></name><name><surname>Scott</surname><given-names>F. J.</given-names></name><name><surname>Bolton</surname><given-names>P. F.</given-names></name><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name><name><surname>Matthews</surname><given-names>F. E.</given-names></name><name><surname>Brayne</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>The Childhood Autism Spectrum Test (CAST): sex differences</article-title>. <source>J. Autism Dev. Disord.</source>
<volume>38</volume>, <fpage>1731</fpage>&#x02013;<lpage>1739</lpage><pub-id pub-id-type="doi">10.1007/s10803-008-0558-6</pub-id><pub-id pub-id-type="pmid">18408991</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winslow</surname><given-names>J. T.</given-names></name><name><surname>Insel</surname><given-names>T. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Neuroendocrine basis of social recognition</article-title>. <source>Curr. Opin. Neurobiol.</source>
<volume>14</volume>, <fpage>248</fpage>&#x02013;<lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2004.03.009</pub-id><pub-id pub-id-type="pmid">15082332</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolrich</surname><given-names>M. W.</given-names></name><name><surname>Ripley</surname><given-names>B. D.</given-names></name><name><surname>Brady</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>S. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Temporal autocorrelation in univariate linear modeling of FMRI data</article-title>. <source>Neuroimage</source>
<volume>14</volume>, <fpage>1370</fpage>&#x02013;<lpage>1386</lpage><pub-id pub-id-type="doi">10.1006/nimg.2001.0931</pub-id><pub-id pub-id-type="pmid">11707093</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Worsley</surname><given-names>K. J.</given-names></name></person-group> (<year>2001</year>). <article-title>&#x0201c;Statistical analysis of activation images,&#x0201d;</article-title>
<source>in Functional MRI: An Introduction to Methods</source>, <person-group person-group-type="editor"><name><surname>Jezzard</surname><given-names>P.</given-names></name><name><surname>Matthews</surname><given-names>P. H.</given-names></name><name><surname>Smith</surname><given-names>S. M.</given-names></name></person-group> (<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>), <fpage>251</fpage>&#x02013;<lpage>270</lpage></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>P. J.</given-names></name><name><surname>Kurzban</surname><given-names>R.</given-names></name><name><surname>Matzner</surname><given-names>W. T.</given-names></name></person-group> (<year>2005</year>). <article-title>Oxytocin is associated with human trustworthiness</article-title>. <source>Horm. Behav.</source>
<volume>48</volume>, <fpage>522</fpage>&#x02013;<lpage>527</lpage><pub-id pub-id-type="doi">10.1016/j.yhbeh.2005.07.009</pub-id><pub-id pub-id-type="pmid">16109416</pub-id></mixed-citation></ref></ref-list></back></article>